Trials / Conditions / Allergic Contact Dermatitis

Allergic Contact Dermatitis

25 registered clinical trials studyying Allergic Contact Dermatitis — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Rate of Allergic Contact Dermatitis and Cosmetic Outcomes NCT06957444	West Virginia University	N/A
Recruiting	Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases NCT06529913	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	N/A
Not Yet Recruiting	Characterization of Visual Characteristics in Allergic Contact Dermatitis Using the Skincam® Tool NCT06351449	Hospices Civils de Lyon	—
Unknown	Patient Experience and Quality of Patch Testing on the Legs vs Back NCT06191627	HealthPartners Institute	N/A
Unknown	Repeated Open Application Test (ROAT) Study With Hydroperoxides of Linalool NCT05858723	National Allergy Research Center, Denmark	N/A
Unknown	A Prospective Study to Investigate Contact Sensitization Using Classic and Machine Learning Techniques NCT05991674	Andreas Syggros Hospital of Venereal and Dermatological Diseases	—
Recruiting	Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation NCT05535738	Wei-Che Ko	Phase 2 / Phase 3
Completed	The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis NCT05498467	Herlev and Gentofte Hospital	Phase 3
Completed	Allergy Skin Patch Artificial Intelligence (AI) NCT05339750	Mayo Clinic	N/A
Completed	Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions in Health NCT03945760	Wright State Physicians	EARLY_Phase 1
Active Not Recruiting	The Effects of Dupilumab on Allergic Contact Dermatitis NCT03935971	Brigham and Women's Hospital	Phase 4
Completed	Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis NCT03680131	Edesa Biotech Inc.	Phase 2
Completed	MicroRNA-126 and Its Target VCAM-1Dermatitis to Nickel NCT04365140	Universidad Autonoma de San Luis Potosí	—
Completed	Red Grape Polyphenol Oral Administration to Women Affected by Nickel-mediated Allergic Contact Dermatitis NCT03902392	University of Bari	N/A
Completed	Epidemiology and Co-Reactivity of Novel Surfactant Allergens NCT02534441	Minneapolis Veterans Affairs Medical Center	N/A
Completed	Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents NCT01797562	Allerderm	N/A
Completed	Bioequivalence of Ethylenediamine Dihydrochloride Study NCT01798589	Allerderm	Phase 4
Completed	Immune Reactions in Contact Dermatitis Affected Skin NCT01546298	Rockefeller University	—
Unknown	Nickel Desensitization Using Topical Therapy NCT01413477	University of British Columbia	N/A
Completed	Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatit NCT00867607	Hadassah Medical Organization	Phase 1 / Phase 2
Completed	Study of Apremilast in Atopic or Contact Dermatitis NCT00931242	Tufts Medical Center	Phase 2
Unknown	Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular a NCT00445029	Hospices Civils de Lyon	—
Completed	Clinical Evaluation of Bacitracin NCT00132600	Mekos Laboratories AS	Phase 2
Completed	Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate NCT00133341	Mekos Laboratories AS	Phase 2
Completed	NI-0801 in Allergic Contact Dermatitis NCT01244607	Light Chain Bioscience - Novimmune SA	Phase 1